Patients with no schooling benefit least from blood thinning medications

(European Society of Cardiology) Patients with no schooling benefit least from blood thinning medications, reveals a European Heart Rhythm Association/European Society of Cardiology survey published today in Europace. The poll of more than 1,100 patients with atrial fibrillation found those with no schooling missed treatment targets more often, were less aware of bleeding risks, and did not know they could continue normal daily activities.